Puma Biotechnology (PBYI)
(Delayed Data from NSDQ)
$5.02 USD
+0.14 (2.87%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $5.01 -0.01 (-0.20%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth C Momentum A VGM
Cash flow Statements
Fiscal Year End for Puma Biotechnology, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 21.59 | 0.00 | -29.13 | -60.00 | -75.60 |
Depreciation/Amortization & Depletion | 11.52 | 8.92 | 10.60 | 10.03 | 8.08 |
Net Change from Assets/Liabilities | -17.85 | -43.58 | -0.60 | 13.16 | 23.28 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 11.75 | 18.83 | 39.78 | 37.58 | 66.61 |
Net Cash From Operating Activities | 27.01 | -15.83 | 20.65 | 0.77 | 22.38 |
Property & Equipment | -0.14 | 0.00 | 0.00 | -0.05 | -0.31 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -6.49 | 14.10 | -10.88 | 43.45 | 5.47 |
Other Investing Activities | -12.50 | -7.00 | 0.00 | -20.00 | 0.00 |
Net Cash from Investing Activities | -19.13 | 7.10 | -10.88 | 23.40 | 5.16 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 12.50 | 0.00 | 0.07 | 1.35 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | -1.50 | 0.00 | -55.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | -0.28 | -30.43 | 0.00 | -13.42 |
Net Cash from Financing Activities | 0.00 | 12.22 | -31.93 | 0.07 | -67.07 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 7.88 | 3.50 | -22.16 | 24.24 | -39.53 |
Cash at Beginning of Period | 78.79 | 75.29 | 97.45 | 73.21 | 112.74 |
Cash at End of Period | 86.68 | 78.79 | 75.29 | 97.45 | 73.21 |
Diluted Net EPS | 0.45 | 0.00 | -0.72 | -1.52 | -1.95 |
Fiscal Year End for Puma Biotechnology, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | 21.59 | 9.32 | 3.53 | 1.40 |
Depreciation/Amortization & Depletion | NA | 11.52 | 8.63 | 5.75 | 2.88 |
Net Change from Assets/Liabilities | NA | -17.85 | -10.35 | -9.13 | -4.47 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 11.75 | 8.95 | 5.78 | 2.84 |
Net Cash From Operating Activities | NA | 27.01 | 16.55 | 5.94 | 2.64 |
Property & Equipment | NA | -0.14 | -0.10 | -0.07 | 0.00 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | -6.49 | 1.64 | -9.57 | -4.95 |
Other Investing Activities | NA | -12.50 | -12.50 | -12.50 | -12.50 |
Net Cash from Investing Activities | NA | -19.13 | -10.96 | -22.13 | -17.45 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | 7.88 | 5.60 | -16.19 | -14.81 |
Cash at Beginning of Period | NA | 78.79 | 78.79 | 78.79 | 78.79 |
Cash at End of Period | NA | 86.68 | 84.39 | 62.60 | 63.99 |
Diluted Net EPS | NA | 0.25 | 0.12 | 0.05 | 0.03 |